Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the self-renewal and pluripotency of human embryonic stem cells via the control of the G1/S transition

Stem Cells

Volumn 31, Issue 12, 2013, Pages 2647-2658

  Choi, Hong Seo ^a   Lee, Hyun Min ^a   Jang, Young Joo ^b   Kim, Cheorl Ho ^c   Ryu, Chun Jeih ^a  

^a Sejong University   (South Korea)

^b Dankook University   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

G1 S transition; HnRNP A2 B1; Human embryonic stem cells; PI3K Akt; Pluripotency; Self renewal

Indexed keywords

ALKALINE PHOSPHATASE; CHECKPOINT KINASE 1; CYCLIN D1; CYCLIN E; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P53; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; HNRNP A2; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; EPITHELIAL MESENCHYMAL TRANSITION; G1 PHASE CELL CYCLE CHECKPOINT; GERM LAYER; HUMAN; HUMAN CELL; MARKER GENE; PHENOTYPE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; BIOSYNTHESIS; CELL CYCLE S PHASE; CELL GROWTH; COCULTURE; CYTOLOGY; DOWN REGULATION; FIBROBLAST; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; COCULTURE TECHNIQUES; DOWN-REGULATION; EMBRYONIC STEM CELLS; FIBROBLASTS; G1 PHASE; GENE KNOCKDOWN TECHNIQUES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PLURIPOTENT STEM CELLS; S PHASE; TRANSFECTION;

EID: 84881174308     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1366     Document Type: Article

References (77)

1. Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 2005;6:872-884.
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
3. Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956.
4. Boyer LA, Mathur D, Jaenisch R. Molecular control of pluripotency. Curr Opin Genet Dev 2006;16:455-462.
5. Martinez-Contreras R, Cloutier P, Shkreta L et al. hnRNP proteins and splicing control. Adv Exp Med Biol 2007;623:123-147.
6. Burd CG, Swanson MS, Gorlach M et al. Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 Proteins: A diversity of RNA binding proteins is generated by small peptide inserts. Proc Natl Acad Sci USA 1989;86:9788-9792.
7. Kozu T, Henrich B, Schafer KP. Structure and expression of the gene (HNRPA2B1) encoding the human hnRNP protein A2/B1. Genomics 1995;25:365-371.
8. Mayeda A, Munroe SH, Caceres JF et al. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J 1994;13:5483-5495.
9. Nakielny S, Fischer U, Michael WM et al. RNA transport. Annu Rev Neurosci 1997;20:269-301.
10. Goodarzi H, Najafabadi HS, Oikonomou P et al. Systematic discovery of structural elements governing stability of mammalian messenger RNAs. Nature 2012;485:264-268.
11. Moran-Jones K, Wayman L, Kennedy DD et al. hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Res 2005;33:486-496.
12. Wu S, Sato M, Endo C et al. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer 2003;41:179-186.
13. Ushigome M, Ubagai T, Fukuda H et al. Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers. Int J Oncol 2005;26: 635-640.
14. Zhou J, Allred DC, Avis I et al. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein- A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 2001;66:217-224.
15. Yan-Sanders Y, Hammons GJ, Lyn-Cook BD. Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett 2002; 183:215-220.
16. Lee CH, Lum JH, Cheung BP et al. Identification of the heterogeneous nuclear ribonucleoprotein A2/B1 as the antigen for the gastrointestinal cancer specific monoclonal antibody MG7. Proteomics 2005;5: 1160-1166.
17. Jing GJ, Xu DH, Shi SL et al. Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma. J Gastroenterol Hepatol 2011;26:108-115.
18. Liang Y, Shi SL, Li QF et al. The localization of hnRNP A2/B1 in nuclear matrix and the aberrant expression during the RA-induced differentiation of human neuroblastoma SK-N-SH cells. J Cell Biochem 2011;112:1722-1729.
19. David CJ, Chen M, Assanah M et al. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010;463:364-368.
20. Takimoto M, Tomonaga T, Matunis M et al. Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. J Biol Chem 1993;268:18249-18258.
21. Campillos M, Lamas JR, Garcia MA et al. Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the -219T allelic form modulates APOE promoter activity. Nucleic Acids Res 2003;31: 3063-3070.
22. Chen H, Hewison M, Hu B et al. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance. Proc Natl Acad Sci USA 2003;100:6109-6114.
23. Thakur S, Nakamura T, Calin G et al. Regulation of BRCA1 transcription by specific single-stranded DNA binding factors. Mol Cell Biol 2003;23:3774-3787.
24. Zhao S, Korzan WJ, Chen CC et al. Heterogeneous nuclear ribonucleoprotein A/B and G inhibits the transcription of gonadotropinreleasing- hormone 1. Mol Cell Neurosci 2008;37:69-84.
25. Guha M, Fang JK, Monks R et al. Activation of Akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2. Mol Biol Cell 2010;21:3578-3589.
26. Guha M, Pan H, Fang JK et al. Heterogeneous nuclear ribonucleoprotein A2 is a common transcriptional coactivator in the nuclear transcription response to mitochondrial respiratory stress. Mol Biol Cell 2009;20:4107-4119.
27. Choi HS, Kim H, Won A et al. Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells. Cell Tissue Res 2008;333:197-206.
28. Choi HS, Kim WT, Kim H et al. Identification and characterization of adenovirus early region 1B-Associated protein 5 as a surface marker on undifferentiated human embryonic stem cells. Stem Cells Dev 2011;20:609-620.
29. Xu C, Inokuma MS, Denham J et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001;19: 971-974.
30. Ryu CJ, Whitehurst CE, Chen J. Expression of Gal4-VP16 and Gal4- DNA binding domain under the control of the T lymphocyte-specific lck proximal promoter in transgenic mice. BMB Rep 2008;41: 575-580.
31. Cheng M, Chen Y, Yu X et al. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer. BMC Cancer 2008;8:156.
32. Cox JL, Mallanna SK, Ormsbee BD et al. Banf1 is required to maintain the self-renewal of both mouse and human embryonic stem cells. J Cell Sci 2011;124:2654-2665.
33. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
34. Arnold DR, Bordignon V, Lefebvre R et al. Somatic cell nuclear transfer alters peri-implantation trophoblast differentiation in bovine embryos. Reproduction 2006;132:279-290.
35. Bravo-Cuellar A, Ortiz-Lazareno PC, Lerma-Diaz JM et al. Sensitization of cervix cancer cells to adriamycin by pentoxifylline induces an increase in apoptosis and decrease senescence. Mol Cancer 2010;9: 114.
36. Becker KA, Ghule PN, Therrien JA et al. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol 2006;209:883-893.
37. Yoon IS, Chung JH, Hahm SH et al. Ribosomal protein S3 is phosphorylated by Cdk1/cdc2 during G2/M phase. BMB Rep 2011;44: 529-534.
38. Bendall SC, Stewart MH, Menendez P et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007;448:1015-1021.
39. Li L, Wang S, Jezierski A et al. A unique interplay between Rap1 and E-cadherin in the endocytic pathway regulates self-renewal of human embryonic stem cells. Stem Cells 2010;28:247-257.
40. Chambers I, Colby D, Robertson M et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003;113:643-655.
41. Niwa H. How is pluripotency determined and maintained? Development 2007;134:635-646.
42. Wang G, Xiao Q, Luo Z et al. Functional impact of heterogeneous nuclear ribonucleoprotein A2/B1 in smooth muscle differentiation from stem cells and embryonic arteriogenesis. J Biol Chem 2012;287: 2896-2906.
43. Eastham AM, Spencer H, Soncin F et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 2007;67:11254-11262.
44. Ullmann U, Gilles C, De Rycke M et al. GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions. Mol Hum Reprod 2008;14: 169-179.
45. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-1428.
46. Tauler J, Zudaire E, Liu H et al. hnRNP A2/B1 modulates epithelialmesenchymal transition in lung cancer cell lines. Cancer Res 2010;70: 7137-7147.
47. He Y, Brown MA, Rothnagel JA et al. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J Cell Sci 2005;118: 3173-3183.
48. He Y, Rothnagel JA, Epis MR et al. Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation. Mol Carcinog 2009;48:167-179.
49. Neganova I, Zhang X, Atkinson S et al. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 2009;28:20-30.
50. Neganova I, Vilella F, Atkinson SP et al. An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 2011;29:651-659.
51. Neganova I, Vilella F, Atkinson SP et al. An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 2011;29:651-659.
52. Gu Y, Rosenblatt J, Morgan DO. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J 1992;11: 3995-4005.
53. Sherr CJ, Roberts JM. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-1512.
54. Zhu D, Xu G, Ghandhi S et al. Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: Implications for cellular senescence. J Cell Physiol 2002;193:19-25.
55. Barta T, Vinarsky V, Holubcova Z et al. Human embryonic stem cells are capable of executing G1/S checkpoint activation. Stem Cells 2010; 28:1143-1152.
56. Qin H, Yu T, Qing T et al. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 2007;282: 5842-5852.
57. Mailand N, Falck J, Lukas C et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000;288:1425-1429.
58. Li J, Wang G, Wang C et al. MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal. Differentiation 2007;75:299-307.
59. Ding VM, Ling L, Natarajan S et al. FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/ GSK3beta signaling. J Cell Physiol 2010;225:417-428.
60. Armstrong L, Hughes O, Yung S et al. The role of PI3K/AKT, MAPK/ERK and Nfkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 2006;15: 1894-1913.
61. Eiselleova L, Matulka K, Kriz V et al. A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells. Stem Cells 2009;27:1847-1857.
62. Assou S, Le Carrour T, Tondeur S et al. A meta-Analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 2007;25:961-973.
63. Van Hoof D, Munoz J, Braam SR et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009;5:214-226.
64. Prokhorova TA, Rigbolt KT, Johansen PT et al. Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol Cell Proteomics 2009;8:959-970.
65. Dormeyer W, van Hoof D, Braam SR et al. Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J Proteome Res 2008;7:2936-2951.
66. McQuade LR, Schmidt U, Pascovici D et al. Improved membrane proteomics coverage of human embryonic stem cells by peptide IPG-IEF. J Proteome Res 2009;8:5642-5649.
67. Patry C, Bouchard L, Labrecque P et al. Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines. Cancer Res 2003;63:7679-7688.
68. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-1163.
69. Bryja V, Cajanek L, Pachernik J et al. Abnormal development of mouse embryoid bodies lacking p27Kip1 cell cycle regulator. Stem Cells 2005;23:965-974.
70. White J, Dalton S. Cell cycle control of embryonic stem cells. Stem Cell Rev 2005;1:131-138.
71. Egozi D, Shapira M, Paor G et al. Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells. FASEB J 2007;21:2807-2817.
72. Bryja V, Pachernik J, Soucek K et al. Increased apoptosis in differentiating p27-deficient mouse embryonic stem cells. Cell Mol Life Sci 2004;61:1384-1400.
73. Xu Y. A new role for p53 in maintaining genetic stability in embryonic stem cells. Cell Cycle 2005;4:363-364.
74. Zhang X, Neganova I, Przyborski S et al. A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J Cell Biol 2009;184:67-82.
75. Lange C, Calegari F. Cdks and cyclins link G1 length and differentiation of embryonic, neural and hematopoietic stem cells. Cell Cycle 2010;9:1893-1900.
76. Jirmanova L, Afanassieff M, Gobert-Gosse S et al. Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 2002;21:5515-5528.
77. Reichert M, Saur D, Hamacher R et al. Phosphoinositide-3-kinase signaling controls S-phase kinase-Associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res 2007;67: 4149-4156.